Company news

Arctic Bioscience AS news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Arctic Bioscience - Strong revenue growth and new data on HRO350 complementing the HeROPA trial results

August 27, 2026

Arctic Bioscience presents HeROPA data at EADV in Athens

May 8, 2026

Arctic Bioscience AS: Consolidated 2025 Annual Report

May 7, 2026

Arctic Bioscience - Annual report 2025

May 7, 2026

Presentation of Q1-2026 update

April 30, 2026

Arctic Bioscience - 78% growth in Nutra revenues

April 30, 2026

Arctic Bioscience - Invitation to presentation of Q1 2026 operational update

April 24, 2026

Arctic Bioscience - Primary insiders who have provided bank guarantee

April 1, 2026

Arctic Bioscience - New long-term financing

April 1, 2026

Arctic Bioscience - New peer-reviewed study shows herring roe phospholipids stimulate anti-inflammatory pathways in cells

March 19, 2026

Presentation of Q4-2025 update

February 26, 2026

Arctic Bioscience - Q4 2025 Operational update - Positive outlook for 2026

February 26, 2026

Arctic Bioscience - Invitation to presentation of Q4 2025 operational update

February 23, 2026

Arctic Bioscience - Share capital increase registered

December 17, 2025

Arctic Bioscience - Board approval of share capital increase related to conversion of debt

December 12, 2025

Arctic Bioscience - Exercise of right to convert debt and issuance of shares

December 9, 2025

Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation

November 10, 2025

Arctic Bioscience - Invitation to presentation of Q3 operational update and HeROPA-analyses results

November 7, 2025

Arctic Bioscience - Analysis on HeROPA study shows statistically significant effects of psoriasis drug candidate HRO350 on inflammation

November 4, 2025

Decks